Early screening to find gestational diabetes in pregnancy
Official title: Early Detection of Gestational Diabetes Mellitus in Pregnancy: A Randomized Trial
Run by University of Massachusetts, Worcester · NCT05388643 · Data updated 2026-11-12
This project tries a first-trimester blood screening to see if it finds gestational diabetes earlier in pregnant people at high risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | University of Massachusetts, Worcester Academic / other |
| Locations | 1 site (Worcester, Massachusetts) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | April 6, 2026 |
| Trial ID | NCT05388643 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant people aged 18 or older with a singleton pregnancy at or before 12 weeks, receiving prenatal care and planning delivery at UMMHC, who meet ACOG high-risk criteria and speak English or Spanish are ideal candidates.
✕Probably not a fit
People with preexisting diabetes, those unable to complete an oral glucose tolerance test, those on systemic steroids, or those planning care outside UMMHC are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Gestational diabetes increases risks for both mothers and newborns and is typically screened for in the second trimester. This pilot randomized controlled trial will enroll 80 high-risk pregnant people before 12 weeks at UMass Memorial; half will receive a protocolized first-trimester serum biomarker screen and half will receive standard screening at 24–28 weeks with possible early screening at provider discretion. The study will test the feasibility and acceptability of implementing early screening and compare timing of detection and related maternal and neonatal outcomes. Investigators will use clinical data and participant feedback to refine the protocol for potential broader use.
Why it matters
Potential benefit: If successful, earlier detection could allow earlier treatment and monitoring to reduce pregnancy and newborn complications.
How similar studies have gone: Prior work on first-trimester biomarker screening for gestational diabetes has shown mixed results, so this pilot focuses on feasibility and implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\) age greater than or equal to 18 years old, * 2\) singleton gestation less than or equal to 12 weeks at initial obstetric visit, * 3\) receiving prenatal care at UMMHC and plans to deliver at UMMHC, * 4\) able and willing to provide informed consent, * 5\) English or Spanish speaking, and * 6\) are at high risk for developing GDM by ACOG clinical risk factor guidelines. Exclusion Criteria: * 1\) known diagnosis of pre-existing pregestational diabetes, * 2\) plan to receive prenatal care or deliver outside of UMMHC, * 3\) inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test), or * 4\) systemic steroid use.
Where it's running
-
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Gianna Wilkie, MD — University of Massachusetts, Worcester
- Study coordinator: Gianna L Wilkie, MD
- Email: Gianna.Wilkie@umassmemorial.org
- Phone: 77743642523
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
NOURISH: a community partnership to improve nutrition and glycemic control in pregnant women with pregestational diabetes
Aiming to test a healthcare-community program that delivers healthy food weekly and provides nutrition education to pregnant women with type 1 or type 2 diabetes who have food insecurity, to improve blood sugar and pregnancy outcomes.
-
Behavioral toolkit to help pregnant women manage gestational diabetes and pregnancy-related high blood pressure.
This program will test whether a structured behavioral toolkit helps pregnant women with both gestational diabetes and pregnancy-induced high blood pressure better control their blood sugar and blood pressure.
-
MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy
This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.